These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8957691

  • 1. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
    Delsite R, Djakiew D.
    J Androl; 1996; 17(5):481-90. PubMed ID: 8957691
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
    Zolfaghari A, Djakiew D.
    Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
    [Abstract] [Full Text] [Related]

  • 3. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate.
    Djakiew D, Delsite R, Pflug B, Wrathall J, Lynch JH, Onoda M.
    Cancer Res; 1991 Jun 15; 51(12):3304-10. PubMed ID: 1710170
    [Abstract] [Full Text] [Related]

  • 4. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
    Dionne CA, Camoratto AM, Jani JP, Emerson E, Neff N, Vaught JL, Murakata C, Djakiew D, Lamb J, Bova S, George D, Isaacs JT.
    Clin Cancer Res; 1998 Aug 15; 4(8):1887-98. PubMed ID: 9717816
    [Abstract] [Full Text] [Related]

  • 5. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
    Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE.
    Cancer Res; 1995 May 15; 55(10):2212-9. PubMed ID: 7538048
    [Abstract] [Full Text] [Related]

  • 6. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line.
    Westphal G, van den Berg-Stein S, Braun K, Knoch TA, Dümmerling M, Langowski J, Debus J, Friedrich E.
    J Exp Clin Cancer Res; 2002 Jun 15; 21(2):255-67. PubMed ID: 12148587
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Jun 15; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 9. Trk receptor inhibition induces apoptosis of proliferating but not quiescent human osteoblasts.
    Pinski J, Weeraratna A, Uzgare AR, Arnold JT, Denmeade SR, Isaacs JT.
    Cancer Res; 2002 Feb 15; 62(4):986-9. PubMed ID: 11861369
    [Abstract] [Full Text] [Related]

  • 10. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT.
    Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749
    [Abstract] [Full Text] [Related]

  • 11. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction.
    Chin LS, Murray SF, Zitnay KM, Rami B.
    Clin Cancer Res; 1997 May 15; 3(5):771-6. PubMed ID: 9815748
    [Abstract] [Full Text] [Related]

  • 12. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Oncol Rep; 2008 Mar 15; 19(3):749-53. PubMed ID: 18288411
    [Abstract] [Full Text] [Related]

  • 13. Expression of a Trk high affinity nerve growth factor receptor in the human prostate.
    Pflug BR, Dionne C, Kaplan DR, Lynch J, Djakiew D.
    Endocrinology; 1995 Jan 15; 136(1):262-8. PubMed ID: 7828539
    [Abstract] [Full Text] [Related]

  • 14. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
    Weeraratna AT, Dalrymple SL, Lamb JC, Denmeade SR, Miknyoczki S, Dionne CA, Isaacs JT.
    Clin Cancer Res; 2001 Aug 15; 7(8):2237-45. PubMed ID: 11489797
    [Abstract] [Full Text] [Related]

  • 15. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
    Katner AL, Hoang QB, Gootam P, Jaruga E, Ma Q, Gnarra J, Rayford W.
    Prostate; 2002 Sep 15; 53(1):77-87. PubMed ID: 12210483
    [Abstract] [Full Text] [Related]

  • 16. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 17. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
    Sosnowski J, Stetter-Neel C, Cole D, Durham JP, Mawhinney MG.
    J Urol; 1997 Jul 15; 158(1):269-74. PubMed ID: 9186373
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
    Pidgeon GP, Kandouz M, Meram A, Honn KV.
    Cancer Res; 2002 May 01; 62(9):2721-7. PubMed ID: 11980674
    [Abstract] [Full Text] [Related]

  • 19. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
    Festuccia C, Muzi P, Gravina GL, Millimaggi D, Speca S, Dolo V, Ricevuto E, Vicentini C, Bologna M.
    Int J Oncol; 2007 Jan 01; 30(1):193-200. PubMed ID: 17143529
    [Abstract] [Full Text] [Related]

  • 20. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.
    Cancer Res; 2001 Jul 15; 61(14):5432-40. PubMed ID: 11454688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.